Purchases and Sales Made in Q4 2023 in Inhibrx, Inc. (INBX)
This table provides information about the institutional ownership of Inhibrx, Inc. (INBX) during Q4 2023. The information is specifically focused on institutions that hold shares of Inhibrx, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2024
Q4 2023
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-99.4K- 32.04% |
$1.44M - $3.78M
|
211K
$3M
|
|
|
Feb 13, 2024
Q4 2023
|
Schroder Investment Management Group
London, X0 |
SELL
|
- |
-106K- 44.7% |
$1.54M - $4.03M
|
131K
$1.87M
|
|
|
Feb 14, 2024
Q4 2023
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-200K- 96.2% |
$2.9M - $7.59M
|
7.9K
$112K
|
|
|
Feb 12, 2024
Q4 2023
|
Sofinnova Investments, Inc.
Menlo Park, CA |
SELL
|
- |
-225K- 22.57% |
$3.27M - $8.56M
|
773K
$11M
|
|
|
Feb 12, 2024
Q4 2023
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-318K- 86.07% |
$4.62M - $12.1M
|
51.5K
$732K
|
|
|
Feb 13, 2024
Q4 2023
|
Capital Research Global Investors
Los Angeles, CA |
SELL
|
- |
-509K- 41.69% |
$7.39M - $19.4M
|
712K
$10.1M
|
|
|
Feb 14, 2024
Q4 2023
|
Soleus Capital Management, L.P.
Greenwich, CT |
SELL
|
- |
-534K- 97.27% |
$7.75M - $20.3M
|
15K
$213K
|